Clever Culture Systems: Half Yearly Report and Accounts
Filed with ASX · · 23 pages · English
This information should be read in conjunction with the 30 June 2025 Annual Report and any public announcements made by Clever Culture Systems Limited during the interim reporting period in accordance with the continuous disclosure requirements of the Corporations Act 2001. RESULTS FOR ANNOUNCEMENT TO THE MARKET (Appendix 4D) Revenue Revenue from Ordinary Activities for the half year ended 31 Dece
Clever Culture Systems Limited on 6ix
Earlier from Clever Culture Systems
- Quarterly Activities/Appendix 4C Cash Flow Report
- Appendix 4E
- APAS Contact Plate Application Product Launch
- Instrument Sale to Novo Nordisk for Group Evaluation
- Additional Four Instruments Ordered by AstraZeneca
Later from Clever Culture Systems
- Novo Nordisk Expand Use of APAS Independence
- PSC Biotech Partnership Expands US Pharma Sales Reach
- Advancing Sales Pipeline Underpins Growth Momentum
- Trading Halt
- Funding Raised for Development of a New Benchtop Instrument
Follow Clever Culture Systems into a list and get an email when it puts out news.
Follow Clever Culture Systems